当前位置:首页 - 行情中心 - 益盛药业(002566) - 财务分析 - 资产负债表

益盛药业

(002566)

  

流通市值:16.39亿  总市值:23.40亿
流通股本:2.32亿   总股本:3.31亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金565,651,644.14487,733,640.95446,022,778.54426,920,881.92
应收票据及应收账款169,230,467.46155,207,782.41186,885,606.39175,170,234.9
其中:应收票据945,342.671,472,503.221,402,899.821,646,178.01
应收账款168,285,124.79153,735,279.19185,482,706.57173,524,056.89
应收款项融资30,855,507.0943,324,474.2640,929,904.9757,489,663.52
预付款项3,368,661.139,908,158.66,350,916.458,026,868.43
应收保费--4,223,230.59-
其他应收款合计4,426,273.8911,196,279.43-7,959,741.35
存货1,621,047,721.781,616,747,623.931,613,630,489.161,594,013,077.68
其他流动资产3,923,841.793,966,8631,761,751.811,857,954.8
流动资产平衡项目0000
流动资产合计2,450,747,115.542,431,067,051.022,400,754,341.422,371,324,153.63
非流动资产:
固定资产465,568,774.15475,223,375.66484,841,675.35493,169,849.23
在建工程--400,000400,000
使用权资产7,983,456.88,438,343.9712,615,892.2612,993,685.7
无形资产113,508,258.57114,182,579.05114,895,018.2115,603,760.31
商誉1,905,827.331,905,827.331,905,827.331,905,827.33
长期待摊费用1,844,244.782,017,335.172,374,112.442,584,864.78
递延所得税资产12,867,339.4712,618,908.1113,953,543.8413,848,648.86
其他非流动资产742,0001,269,0201,270,610975,560
非流动资产平衡项目0000
非流动资产合计604,419,901.1615,655,389.29632,256,679.42641,482,196.21
资产平衡项目0000
资产总计3,055,167,016.643,046,722,440.313,033,011,020.843,012,806,349.84
流动负债:
短期借款470,418,500.01470,432,666.67470,393,333.32470,393,333.34
应付票据及应付账款17,101,485.9324,864,642.4724,816,611.8221,985,039.26
应付账款17,101,485.9324,864,642.4724,816,611.8221,985,039.26
合同负债10,474,062.7811,011,367.4115,954,59613,534,213.8
应付职工薪酬9,984,724.1811,958,841.486,959,935.137,909,207.57
应交税费16,873,032.413,866,882.3511,484,997.0216,282,821.34
其他应付款合计49,342,910.4454,110,840.9177,897,484.3169,222,783.62
应付股利---16,547,580
一年内到期的非流动负债2,345,375.642,337,273.343,134,811.13,121,971.55
其他流动负债1,191,472.011,262,762.681,902,092.341,585,687.88
流动负债平衡项目0000
流动负债合计577,731,563.39589,845,277.31612,543,861.04604,035,058.36
非流动负债:
租赁负债2,708,523.884,026,407.867,269,562.697,692,339.59
递延收益119,289,257.7118,693,730.56118,894,288.52117,124,723.77
递延所得税负债1,600,523.71,736,282.81,223,713.091,108,608.47
非流动负债平衡项目0000
非流动负债合计123,598,305.28124,456,421.22127,387,564.3125,925,671.83
负债平衡项目0000
负债合计701,329,868.67714,301,698.53739,931,425.34729,960,730.19
所有者权益(或股东权益):
实收资本(或股本)330,951,600330,951,600330,951,600330,951,600
资本公积834,689,338.39834,689,338.39834,689,338.39834,689,338.39
盈余公积140,215,063.74140,215,063.74132,142,747.38132,142,747.38
未分配利润948,323,713.28927,307,333.3899,116,465.58888,075,242.89
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,254,179,715.412,233,163,335.432,196,900,151.352,185,858,928.66
少数股东权益99,657,432.5699,257,406.3596,179,444.1596,986,690.99
股东权益平衡项目0000
股东权益合计2,353,837,147.972,332,420,741.782,293,079,595.52,282,845,619.65
负债和股东权益合计3,055,167,016.643,046,722,440.313,033,011,020.843,012,806,349.84
公告日期2024-04-262024-04-192023-10-272023-08-25
审计意见(境内)标准无保留意见
TOP↑